Hepatitis aguda asociada al consumo de Colpachi. A propósito de 5 casos
Tài liệu tham khảo
Koretz, 2004, Complementary and alternative medicine in gastroenterology: the good, the bad, and the ugly, Clin Gastroenterol Hepatol, 2, 957, 10.1016/S1542-3565(04)00461-6
Levy, 2004, Use of herbal supplements for chronic liver diseases, Clin Gastroenterol Hepatol, 2, 947, 10.1016/S1542-3565(04)00455-0
Tirona, 2006, Herbal product-drug interactions mediated by induction, Br J Clin Pharmacol, 61, 677, 10.1111/j.1365-2125.2006.02684.x
Andrade, 2002, Hepatotoxicidad por infusión de hierbas, Gastroenterol Hepatol, 25, 327, 10.1016/S0210-5705(02)79029-8
Pittler, 2003, Systematic review: hepatotoxic events associated with herbal products, Aliment Pharmacol Ther, 18, 451, 10.1046/j.1365-2036.2003.01689.x
Schiano, 2003, Hepatotoxicity of complementary and alternative medicines, Clin Liver Dis, 7, 453, 10.1016/S1089-3261(03)00030-8
Wurtz, 2002, Possible hepatoxicity from Copaltra, an herbal medicine, Ann Pharmacother, 36, 941, 10.1345/aph.1A163
Vial T, Wurtz AS, Liautard C, Djezzar S. Hepatitis induced by herbal medicines: a report of 5 cases [abstract]. Presented at 6 th Annual Meeting of the European Society of Pharmacovigilance. Budapest, 28-29 de septiembre de 1998.
Ingelmo, 1980, Vascultitis por hipersensibilidad y hepatitis granulomatosa inducida por glibenclamida: descripción de un caso, Med Clin (Barc), 75, 306
González de la Puente, 2001, Fatal hepatotoxiciy associated with enalapril, Ann Pharmacother, 35, 1492, 10.1345/aph.1A055
Paris, 1960, Action hypoglycémiante des Copalchis, Ann Pharmac Franç, 18, 205
Peris, 1995
Agencia Española de Medicamentos y Productos Sanitarios. Suspensión de comercialización de la especialidad farmacéutica Exolise®: extracto etanólico de Camellia sinensis (té verde). Nota informativa 2003/03, 7 de abril de 2003. Disponible en: http://www.agemed.es/actividad/alertas/usoHumano/seguridad/exolise.htm